Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements
This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-10-28
Data overview
- Formats
- HTML
- File languages
- English, French